ERNA vs TER · P/E 0.0, rev $582.0K vs P/E 76, rev $2.82B
Eterna Therapeutics Inc (ERNA) versus Teradyne Inc (TER) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported TER revenue for 2024-12-31 was $2.82B. Net income was $542.4M. Revenue was up 5.4% from 2023-12-31 to 2024-12-31. TER currently screens at market cap $63.96B and trailing P/E 75.7.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. TER currently screens at market cap $63.96B and trailing P/E 75.7.
Not investment advice. Open the ERNA and TER stock pages for the full models.
Not investment advice.